Skip to content

SABSW

SAB Biotherapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.01
−7.89%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 17, 2026
EPS estimate
-$0.27
Revenue estimate
$125.0K

Latest reported

Last report date
Aug 6, 2026
EPS actual
-$0.28
EPS estimate
-$0.28
Revenue actual
Revenue estimate
$125.0K

Track record

Trailing twelve quarters

EPS beats (12Q)
2
EPS misses (12Q)
2
EPS in line (12Q)
0
Avg surprise (4Q)
+31.8%
Revenue beats (12Q)
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 6, 2026-$0.28-$0.28Beat 1.06%
May 12, 2026-$0.21-$0.35Miss -64.73%
Nov 13, 2025-$0.46$0.58Beat 227.42%
Aug 13, 2025-$0.80-$1.09Miss -36.71%
May 9, 2025-$0.56
Sep 29, 2023-$0.10$1.3M

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 17, 2026